243 related articles for article (PubMed ID: 19178506)
1. GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS children.
Hauffa BP; Petersenn S
Clin Endocrinol (Oxf); 2009 Jul; 71(1):155-6. PubMed ID: 19178506
[No Abstract] [Full Text] [Related]
2. Hyperghrelinemia precedes obesity in Prader-Willi syndrome.
Feigerlová E; Diene G; Conte-Auriol F; Molinas C; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2008 Jul; 93(7):2800-5. PubMed ID: 18460565
[TBL] [Abstract][Full Text] [Related]
3. Hyperghrelinemia is a common feature of Prader-Willi syndrome and pituitary stalk interruption: a pathophysiological hypothesis.
Tauber M; Conte Auriol F; Moulin P; Molinas C; Delagnes V; Salles JP
Horm Res; 2004; 62(1):49-54. PubMed ID: 15192277
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
Allen DB; Carrel AL
J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
[TBL] [Abstract][Full Text] [Related]
5. Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome.
Gumus Balikcioglu P; Balikcioglu M; Muehlbauer MJ; Purnell JQ; Broadhurst D; Freemark M; Haqq AM
J Clin Endocrinol Metab; 2015 Oct; 100(10):3822-31. PubMed ID: 26259133
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin levels in young children with Prader-Willi syndrome.
Erdie-Lalena CR; Holm VA; Kelly PC; Frayo RS; Cummings DE
J Pediatr; 2006 Aug; 149(2):199-204. PubMed ID: 16887433
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
[TBL] [Abstract][Full Text] [Related]
9. Analysis of NREM sleep in children with Prader-Willi syndrome and the effect of growth hormone treatment.
Verrillo E; Bruni O; Franco P; Ferri R; Thiriez G; Pavone M; Petrone A; Paglietti MG; Crinò A; Cutrera R
Sleep Med; 2009 Jun; 10(6):646-50. PubMed ID: 19027358
[TBL] [Abstract][Full Text] [Related]
10. [Prader-Willi syndrome. Treatment with growth hormone in 2 cases].
Youlton R
Rev Med Chil; 2001 Oct; 129(10):1186-90. PubMed ID: 11775347
[TBL] [Abstract][Full Text] [Related]
11. The effect of growth hormone on the response of total and acylated ghrelin to a standardized oral glucose load and insulin resistance in children with Prader-Willi syndrome.
Hauffa BP; Haase K; Range IM; Unger N; Mann K; Petersenn S
J Clin Endocrinol Metab; 2007 Mar; 92(3):834-40. PubMed ID: 17192298
[TBL] [Abstract][Full Text] [Related]
12. What is the value of growth hormone therapy in Prader Willi syndrome?
Bridges N
Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi Syndrome during 2 years of growth hormone therapy.
Al-Saleh S; Al-Naimi A; Hamilton J; Zweerink A; Iaboni A; Narang I
J Pediatr; 2013 Feb; 162(2):263-8.e1. PubMed ID: 22947651
[TBL] [Abstract][Full Text] [Related]
14. Acylated and unacylated ghrelin during OGTT in Prader-Willi syndrome: support for normal response to food intake.
Kuppens RJ; Delhanty PJ; Huisman TM; van der Lely AJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2016 Sep; 85(3):488-94. PubMed ID: 26850227
[TBL] [Abstract][Full Text] [Related]
15. Early manifestations of Prader-Willi syndrome: influence of growth hormone.
Eiholzer U; Schlumpf M; Nordmann Y; l'Allemand D
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1441-4. PubMed ID: 11837497
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
Lindgren AC; Lindberg A
Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
[TBL] [Abstract][Full Text] [Related]
17. Prader-Willi syndrome: who can have growth hormone?
Stafler P; Wallis C
Arch Dis Child; 2008 Apr; 93(4):341-5. PubMed ID: 18089632
[TBL] [Abstract][Full Text] [Related]
18. Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005;63:33-39).
Bakker B; Maneatis T; Lippe B
Horm Res; 2007; 67(4):203-4. PubMed ID: 17164585
[No Abstract] [Full Text] [Related]
19. Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome.
Cohen M; Harrington J; Narang I; Hamilton J
Clin Endocrinol (Oxf); 2015 Aug; 83(2):212-5. PubMed ID: 25495188
[TBL] [Abstract][Full Text] [Related]
20. KIGS highlights: growth hormone treatment in Prader-Willi Syndrome.
Tauber M; Cutfield W
Horm Res; 2007; 68 Suppl 5():48-50. PubMed ID: 18174707
[No Abstract] [Full Text] [Related]
[Next] [New Search]
